Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hlc.2013.04.108 | DOI Listing |
J Cardiol Cases
June 2018
Division of Cardiovascular Surgery, Tsuchiya General Hospital, Hiroshima, Japan.
Transcatheter aortic valve implantation (TAVI) has evolved into a standard therapy for aged patients with severe aortic valve stenosis who are not candidates for surgery. However, the reports about the safety of TAVI for patients with dextrocardia situs inversus are few. An 84-year-old man with dextrocardia situs inversus underwent a TAVI for severe aortic stenosis (AS) with an aortic valve area of 0.
View Article and Find Full Text PDFHeart Lung Circ
December 2013
Department of Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN, USA. Electronic address:
Eur J Cardiothorac Surg
October 2013
Department of Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France.
Objectives: Transcatheter aortic valve implantation (TAVI) in patients with poor peripheral vessels still remains problematic, as the transapical approach is not always feasible and is sometimes associated with myocardial damage, bleeding, post-procedural chest pain and pleural effusion. In order to address these issues, we adopted the recently introduced transaortic (TAo) approach. The purpose of this study was to evaluate the efficacy and safety of the TAo-TAVI approach using both the Sapien XT and the CoreValve according to VARC criteria.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!